Abstract
Several viruses, including human papillomaviruses, depend on endosomal acidification for successful infection. Hence, the multisubunit enzyme vacuolar ATPase (V-ATPase), which is mainly responsible for endosome acidification in the cell, represents an attractive target for antiviral strategies. In the present study, we show that V-ATPase is required for human papillomavirus (HPV) infection and that uncoating/disassembly but not endocytosis is affected by V-ATPase inhibition. The infection inhibitory potencies of saliphenylhalamide, a proven V-ATPase inhibitor, and its derivatives, as well as those of other V-ATPase inhibitors, were analyzed on different HPV types in relevant cell lines. Variation in the selectivity indices among V-ATPase inhibitors was high, while variation for the same inhibitor against different HPV subtypes was low, indicating that broad-spectrum anti-HPV activity can be provided.© 2014, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
MÜller, K. H., Spoden, G. A., Scheffer, K. D., Brunnhöfer, R., De Brabander, J. K., Maier, M. E., … Muller, C. P. (2014). Inhibition by cellular vacuolar atpase impairs human papillomavirus uncoating and infection. Antimicrobial Agents and Chemotherapy, 58(5), 2905–2911. https://doi.org/10.1128/AAC.02284-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.